Superior rectal artery embolization for internal hemorrhoids-prospective, randomized controlled, multicenter clinical study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044597

Enrollment

Unknown

Registered

2021-03-24

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

internal hemorrhoids

Interventions

Experimental group:Embolism microspheres

Control group:coil + embolization microsphere

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Comply with hemorrhoids II, III diagnostic criteria; 3. Internal hemorrhoids that failed to be treated conservatively 4. Patients who signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe liver and kidney, heart, brain and lung insufficiency, and abnormal coagulation function; 2. Patients with inflammatory bowel disease highly suggested by past medical history or anorectal colonoscopy; 3. Accompanied by inflammatory external hemorrhoids; 4.Incarcerated hemorrhoids; 5. Complicated with perianal abscess, anal fistula, rectal polyp, intestinal tumor or intestinal infectious disease; 6. Screening patients with pregnancy plan 1 month before, during and 6 months after the study; 7. Pregnant or lactating women; 8. Other patients deemed unsuitable for inclusion by the investigator.

Design outcomes

Primary

Measure	Time frame
Bleeding score;Prolapse score;life quality score;Hospitalization cost;	—

Countries

China

Contacts

Public ContactWujie Wang

The Second Hospital of Shandong University

dr.wangwujie@sdu.edu.cn+86 13791042173

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026